All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @konlan_james on TikTok · 58s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @konlan_james's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Here are a few things I experienced when I had a test level of 161.
  2. 0:04To just put into perspective, a normal range I would say is around 400 to 900 nanograms.
  3. 0:09So 160 is pretty damn low.
  4. 0:11Another reason this happened, I blasted and did a lot of things I probably shouldn't
  5. 0:14have took illegal substances for about 3 years without taking any breaks, no recovery time.
  6. 0:18Yeah, I know it was really stupid.
  7. 0:20But the main side effects I felt when I was 161 nanograms per deciliter is soreness.
  8. 0:25After every session I was sore beyond belief.
  9. 0:27And I wouldn't understand it.
  10. 0:28I was training half as hard in getting twice as sore.
  11. 0:31So recovery plummeted.
  12. 0:32Also, it was hard to sustain mass.
  13. 0:35This is me, I was pretty shredded but I had 190 pounds 6'4.
  14. 0:39That's a little too small.
  15. 0:40The other things I experienced with 161 test hours from the level is sex drive.
  16. 0:43It was non-existent.
  17. 0:45Along with that, I just didn't really want to do much.
  18. 0:47My mental state I was super anxious 24-7.
  19. 0:50But strangely enough, I was motivated 24-7 too just to get in the gym and keep what I
  20. 0:53had.
  21. 0:54I'll see you for the rest of my life because I never bounced back.
  22. 0:57Gear Bloods Check, be smart.

Blood tests and TRT: what 'get your bloods done' actually means

konlan_james

TikTok creator

67.5K viewsWatch on TikTok

Quick answer

The creator describes confirmed total testosterone of 161 ng/dL following multi-year anabolic steroid use without post-cycle recovery, consistent with anabolic steroid-induced hypogonadism (ASIH), a recognized clinical entity involving persistent HPG axis suppression. His reported symptom cluster, including impaired recovery, loss of lean mass, sexual dysfunction, and mood disturbance, aligns with what clinical studies predict at severe androgen deficiency. He reports that testosterone levels never normalized, suggesting possible permanent Leydig cell dysfunction, a documented but not universal outcome of prolonged exogenous androgen use.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 11 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Blood tests and TRT: what 'get your bloods done' actually means, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Blood tests and TRT: what 'get your bloods done' actually means is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Blood tests and TRT: what 'get your bloods done' actually means" from konlan_james. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes confirmed total testosterone of 161 ng/dL following multi-year anabolic steroid use without post-cycle recovery, consistent with anabolic steroid-induced hypogonadism (ASIH), a recognized clinical entity involving persistent HPG axis suppression.

The reason this review is not generic is the source wording and the canonical claim label "trt get those bloods done workout test armanimyway cinderellamov." In this clip, the useful excerpt is: "Here are a few things I experienced when I had a test level of 161." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Anabolic steroid-induced hypogonadism (ASIH) is a documented clinical condition where HPG axis suppression persists after steroid cessation, as described by Rahnema et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes confirmed total testosterone of 161 ng/dL following multi-year anabolic steroid use without post-cycle recovery, consistent with anabolic steroid-induced hypogonadism (ASIH), a recognized clinical entity involving persistent HPG axis suppression.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes confirmed total testosterone of 161 ng/dL following multi-year anabolic steroid use without post-cycle recovery, consistent with anabolic steroid-induced hypogonadism (ASIH), a recognized clinical entity involving persistent HPG axis suppression. His reported symptom cluster, including impaired recovery, loss of lean mass, sexual dysfunction, and mood disturbance, aligns with what clinical studies predict at severe androgen deficiency. He reports that testosterone levels never normalized, suggesting possible permanent Leydig cell dysfunction, a documented but not universal outcome of prolonged exogenous androgen use.
  • Total testosterone below 300 ng/dL on two morning fasting samples meets the Endocrine Society threshold for hypogonadism diagnosis (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).
  • Anabolic steroid-induced hypogonadism (ASIH) is a documented clinical condition where HPG axis suppression persists after steroid cessation, as described by Rahnema et al. (2014, Fertility and Sterility).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Total testosterone below 300 ng/dL on two morning fasting samples meets the Endocrine Society threshold for hypogonadism diagnosis (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).
  • Anabolic steroid-induced hypogonadism (ASIH) is a documented clinical condition where HPG axis suppression persists after steroid cessation, as described by Rahnema et al. (2014, Fertility and Sterility).
  • Symptoms of low testosterone, including poor recovery, low libido, and mood disturbance, are real but non-specific. Labs are required before any clinical diagnosis or treatment decision.
  • LH and FSH levels should be tested alongside total testosterone to distinguish primary hypogonadism from secondary (HPG axis) suppression, especially in anyone with prior steroid use.
  • Not everyone who uses anabolic steroids will experience permanent suppression, but duration of use, compound choice, and absence of recovery periods all increase that risk.
  • Disclosing prior anabolic steroid use to a prescribing clinician is medically necessary. It changes diagnosis, treatment planning, and monitoring requirements significantly.
  • Starting exogenous testosterone without bloodwork in someone with ASIH can further suppress what remaining natural production exists. Testing before treating is not optional.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @konlan_james actually say?

Konlan describes hitting a testosterone level of 161 ng/dL after roughly three years of using anabolic steroids without breaks or post-cycle therapy. He frames 400 to 900 ng/dL as a normal range and lists what he actually felt at that level: extreme post-workout soreness, difficulty holding muscle, a dead sex drive, persistent anxiety, and a strange paradox where he was simultaneously motivated to keep training. His closing line is the most important one: "I'll see you for the rest of my life because I never bounced back."

He is not selling a product here. He is sharing a cautionary account of suppression-induced hypogonadism, apparently permanent, caused by prolonged exogenous androgen use. That framing matters when evaluating what he got right and what deserves more precision.

Does the science back this up?

Mostly, yes. The symptom cluster he describes is clinically consistent with severe hypogonadism, and the mechanism behind it, suppression of the hypothalamic-pituitary-gonadal (HPG) axis from chronic anabolic steroid use, is well-documented.

The HPG axis depends on pulsatile GnRH signaling from the hypothalamus to drive LH and FSH secretion, which in turn tells the testes to produce testosterone. Prolonged exogenous androgen use suppresses this feedback loop. In some men, particularly after years of use without recovery periods, that suppression does not fully reverse. Rahnema et al. (2014, Fertility and Sterility) specifically described anabolic steroid-induced hypogonadism (ASIH) as a recognized clinical entity where Leydig cell function can remain impaired long after cessation.

His reported symptoms map onto what the literature predicts. Bhasin et al. (2001, New England Journal of Medicine) demonstrated dose-dependent relationships between testosterone levels and muscle protein synthesis, fat-free mass retention, and sexual function. At 161 ng/dL, you would expect all three to drop significantly. The anxiety piece is also supported: low testosterone has been associated with increased psychological distress in men, per Zarrouf et al. (2009, Journal of Psychiatric Practice).

What did they get wrong (or right)?

His normal range of 400 to 900 ng/dL is a reasonable lay approximation but slightly imprecise. Most major labs and the American Urological Association peg normal adult male total testosterone between 300 and 1000 ng/dL, with 300 being the common clinical threshold for diagnosing hypogonadism. Calling 160 "pretty damn low" is accurate regardless of which range you use, so this is a minor quibble, not a real error.

What he gets right, and deserves credit for, is not oversimplifying recovery. He does not say "just do PCT and you'll be fine." He says he never bounced back. That honesty is more clinically accurate than most gym content on this topic. Coward et al. (2013, Journal of Urology) found a significant increase in hypogonadism diagnoses among men with prior anabolic steroid use, consistent with his outcome.

What he underplays is the variability. Some men do recover HPG axis function after cessation, particularly younger men with shorter use histories. His case appears to represent a worst-case trajectory, which is real but not universal. Presenting it as the inevitable outcome for anyone who uses steroids would be an overreach, though he stops short of explicitly making that claim.

What should you actually know?

If you are experiencing symptoms like the ones Konlan describes, a single testosterone number tells you only part of the story. Clinicians evaluating for hypogonadism should also look at LH and FSH levels, which can tell you whether the problem is primary (testes not responding) or secondary (HPG axis not signaling). In ASIH, LH and FSH are typically suppressed, not elevated, because the axis has not recovered.

  • Total testosterone below 300 ng/dL on two morning fasting samples is the standard diagnostic threshold per Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).
  • Symptoms alone are not enough to diagnose hypogonadism. Labs are required.
  • Prior anabolic steroid use should be disclosed to your prescribing clinician. It changes the clinical picture entirely, including what treatment options are appropriate.
  • Self-diagnosing from a TikTok symptom list and starting testosterone without bloodwork is how people make the suppression problem significantly worse.

His sign-off, "Gear. Bloods. Check. Be smart," is the most medically sound thing in the video. Get labs before making any decisions about your hormones.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

konlan_james · TikTok creator

67.5K views on this video

Get those bloods done #workout #test #ArmaniMyWay #CinderellaMovie #lifting #lowt #supptok

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about total testosterone below 300 ng/dl on two morning fasting samples?

Total testosterone below 300 ng/dL on two morning fasting samples meets the Endocrine Society threshold for hypogonadism diagnosis (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).

What does the video say about anabolic steroid-induced hypogonadism (asih)?

Anabolic steroid-induced hypogonadism (ASIH) is a documented clinical condition where HPG axis suppression persists after steroid cessation, as described by Rahnema et al. (2014, Fertility and Sterility).

What does the video say about symptoms of low testosterone, including poor recovery, low libido,?

Symptoms of low testosterone, including poor recovery, low libido, and mood disturbance, are real but non-specific. Labs are required before any clinical diagnosis or treatment decision.

What does the video say about lh?

LH and FSH levels should be tested alongside total testosterone to distinguish primary hypogonadism from secondary (HPG axis) suppression, especially in anyone with prior steroid use.

What does the video say about not everyone who uses anabolic steroids will experience permanent suppression,?

Not everyone who uses anabolic steroids will experience permanent suppression, but duration of use, compound choice, and absence of recovery periods all increase that risk.

What does the video say about disclosing prior anabolic steroid use to a prescribing clinician?

Disclosing prior anabolic steroid use to a prescribing clinician is medically necessary. It changes diagnosis, treatment planning, and monitoring requirements significantly.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by konlan_james, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.